Login
From:
Rett Syndrome News
(Uncensored)
subscribe
Rett gene therapy NGN-401 chosen for FDA's START pilot program
https://rettsyndromenews.com/news/rett-gene-therapy-ngn-401-chosen-fdas-start-pilot-program/
links
backlinks
Tagged with:
gene therapy
ngn-401
NGN-401 is one of six picked, three each by the Center for Biologics Evaluation and Research, and the Center for Drug Evaluation and Research.
Roast topics
Find topics
Find it!
